FKBP38 inhibitors (KeyNeurotek/Max-Planck)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameFKBP38 inhibitors (KeyNeurotek/Max-Planck)
Drug Alias NameFK-506 binding protein 38 (KeyNeurotek/Max-Planck)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFK506 binding protein inhibitors
TargetsFK506 binding protein
Therapy Area/IndicationsCentral Nervous System DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKeyneurotek
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMax-Planck-Gesellschaft zur Förderung der Wissenschaften eVKeyneurotek
Active IndicationsN/A
Inactive IndicationsCentral Nervous System DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A